Page last updated: 2024-12-05

n,n-diethylformamide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

N,N-Diethylformamide (DEF) is a colorless liquid that is commonly used as a solvent in various industrial applications. It is synthesized by the reaction of formamide with diethylamine. DEF is known to have various effects, including its use as a solvent for pesticides, herbicides, and resins. It is also employed as a catalyst in organic synthesis. The importance of DEF lies in its ability to dissolve a wide range of organic and inorganic compounds, making it valuable in various industrial processes. Its properties, such as its high boiling point and low viscosity, contribute to its effectiveness as a solvent. Research on DEF focuses on understanding its chemical properties, exploring its potential applications, and assessing its environmental impact. Studies are conducted to evaluate its toxicity, biodegradability, and potential for environmental contamination. These studies are crucial for developing safer and more sustainable industrial practices.'

N,N-diethylformamide: industrial solvent claimed to have HIV protease inhibitory action [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID12051
CHEMBL ID3186600
CHEBI ID183296
SCHEMBL ID27084
MeSH IDM0274833

Synonyms (45)

Synonym
diethylamid kyseliny mravenci
d4blp8bn9h ,
unii-d4blp8bn9h
n,n-diethylormamide
CHEBI:183296
n,n-diethyl-formamide
617-84-5
n-formyldiethylamine
nsc6242
wln: vhn2&2
n,n-diethylformamide
formamide,n-diethyl-
diethylformamide
nsc-6242
formamide, n,n-diethyl-
ai3-11534
diethylamid kyseliny mravenci [czech]
nsc 6242
einecs 210-533-2
diethyl formamide
brn 1209392
inchi=1/c5h11no/c1-3-6(4-2)5-7/h5h,3-4h2,1-2h
formamide, diethyl-
n,n-diethylformamide, 99%
formyldiethylamine
D0506
EN300-91618
NCGC00248876-01
tox21_200919
dtxsid3020463 ,
cas-617-84-5
dtxcid50463
NCGC00258473-01
FT-0629473
AKOS009156839
diethyl-formamide
n,n-diethyl formamide
n.n-diethylformamide
D4234
SCHEMBL27084
CHEMBL3186600
mfcd00003287
Q4044797
AS-17885
CS-W009551
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
carboxamideAn amide of a carboxylic acid, having the structure RC(=O)NR2. The term is used as a suffix in systematic name formation to denote the -C(=O)NH2 group including its carbon atom.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (4)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
AR proteinHomo sapiens (human)Potency16.18190.000221.22318,912.5098AID1259243; AID1259381
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency55.92640.003041.611522,387.1992AID1159555
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency70.40720.001530.607315,848.9004AID1224848; AID1224849
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency28.02960.000627.21521,122.0200AID743202
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (14.29)18.2507
2000's4 (57.14)29.6817
2010's2 (28.57)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.43

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.43 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.51 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.43)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]